BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharifi M, Nazarinia D, Ramezani F, Azizi Y, Naderi N, Aboutaleb N. Necroptosis and RhoA/ROCK pathways: molecular targets of Nesfatin-1 in cardioprotection against myocardial ischemia/reperfusion injury in a rat model. Mol Biol Rep 2021;48:2507-18. [PMID: 33755849 DOI: 10.1007/s11033-021-06289-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Naseroleslami M, Sharifi M, Mousavi Niri N, Aboutaleb N. Simvastatin-loaded nano-niosomes efficiently downregulates the MAPK-NF-κB pathway during the acute phase of myocardial ischemia-reperfusion injury. Mol Biol Rep 2022. [PMID: 36097124 DOI: 10.1007/s11033-022-07891-3] [Reference Citation Analysis]
2 Maslov LN, Popov SV, Naryzhnaya NV, Mukhomedzyanov AV, Kurbatov BK, Derkachev IA, Boshchenko AA, Khaliulin I, Prasad NR, Singh N, Degterev A, Tomilova EA, Sapozhenkova EV. The regulation of necroptosis and perspectives for the development of new drugs preventing ischemic/reperfusion of cardiac injury. Apoptosis. [DOI: 10.1007/s10495-022-01760-x] [Reference Citation Analysis]
3 Ortiz A, Sanz AB. A pathway of osmotic stress-induced necroptosis. Nat Rev Nephrol 2022. [PMID: 35915240 DOI: 10.1038/s41581-022-00607-7] [Reference Citation Analysis]
4 He F, Zheng G, Hu J, Ge W, Ji X, Bradley JL, Peberdy MA, Ornato JP, Tang W. Necrosulfonamide improves post-resuscitation myocardial dysfunction via inhibiting pyroptosis and necroptosis in a rat model of cardiac arrest. Eur J Pharmacol 2022;:175037. [PMID: 35588872 DOI: 10.1016/j.ejphar.2022.175037] [Reference Citation Analysis]
5 Luo Y, Apaijai N, Liao S, Maneechote C, Chunchai T, Arunsak B, Benjanuwattra J, Yanpiset P, Chattipakorn SC, Chattipakorn N. Therapeutic potentials of cell death inhibitors in rats with cardiac ischaemia/reperfusion injury. J Cell Mol Med 2022. [PMID: 35315192 DOI: 10.1111/jcmm.17275] [Reference Citation Analysis]
6 Chen X, Dong J, Jiao Q, Du X, Bi M, Jiang H. "Sibling" battle or harmony: crosstalk between nesfatin-1 and ghrelin. Cell Mol Life Sci 2022;79:169. [PMID: 35239020 DOI: 10.1007/s00018-022-04193-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Fernandez Rico C, Konate K, Josse E, Nargeot J, Barrère-lemaire S, Boisguérin P. Therapeutic Peptides to Treat Myocardial Ischemia-Reperfusion Injury. Front Cardiovasc Med 2022;9:792885. [DOI: 10.3389/fcvm.2022.792885] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Gholamzadeh R, Ramezani F, Tehrani PM, Aboutaleb N. Apelin-13 attenuates injury following ischemic stroke by targeting matrix metalloproteinases (MMP), endothelin- B receptor, occludin/claudin-5 and oxidative stress. J Chem Neuroanat 2021;118:102015. [PMID: 34454018 DOI: 10.1016/j.jchemneu.2021.102015] [Reference Citation Analysis]
9 Dotania K, Tripathy M, Rai U. A comparative account of nesfatin-1 in vertebrates. Gen Comp Endocrinol 2021;312:113874. [PMID: 34331938 DOI: 10.1016/j.ygcen.2021.113874] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Kilian LS, Frank D, Rangrez AY. RhoA Signaling in Immune Cell Response and Cardiac Disease. Cells 2021;10:1681. [PMID: 34359851 DOI: 10.3390/cells10071681] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Naseroleslami M, Niri NM, Akbarzade I, Sharifi M, Aboutaleb N. Simvastatin-loaded nano-niosomes confer cardioprotection against myocardial ischemia/reperfusion injury. Drug Deliv Transl Res 2021. [PMID: 34165730 DOI: 10.1007/s13346-021-01019-z] [Reference Citation Analysis]